13-Year-Old Boy in Michigan Dies Three Days After Getting COVID-19 Shot

by TVR Staff

Published July 4, 2021 | Vaccination, Risk & Failure Reports

The U.S. Centers for Disease Control and Prevention (CDC) is investigating the death of 13-year-old Jacob Clynick in Saginaw, Michigan on June 17, 2021, three days after receiving the second dose of a COVID-19 vaccine. According to the Michigan Department of Health and Human Service (MDHHS), “The investigation as to whether there is a correlation between his death and vaccination is now at the federal level with CDC.”¹

The Saginaw County Health Department did not specify whether the child had developed myocarditis (inflammation of the heart muscle), a condition linked recently to both Pfizer/BioNTech’s experimental

messenger RNA BNT162b2 biologic and Moderns’s experimental mRNA-1273 biologic by the CDC’s Advisory Committee on Immunization Practices (ACIP).^{1 2 3}

Heart Inflammation May Have Played Role in Boy’s Death

There have been reports of a June 20 Twitter post by the boy’s aunt, Tami Burages, indicating child may have developed a heart condition following the vaccination.^{4 5 6} Burages tweeted:

The initial autopsy results (done Friday) were that his heart was enlarged and there was some fluid surrounding it. He had no known health problems. Was on no medications.^{4 5 6}

She added…

The @CDCgov needs to investigate this. There have been other cases of myocarditis in young men receiving their 2nd @pfizer shot. Have others died from it in the United States or is my nephew the first? I think parents should be warned of the risk.^{4 5 6}

Should any innocent child be a sacrificial lamb in this endeavor? There are moral, ethical and health questions that need to be answered. If Jacob had not received the 2nd shot, we believe he would be alive today.⁵

As reported by The Vaccine Reaction:

Based on CDC data, there have been more than 1,200 cases of myocarditis or pericarditis in the United States in people injected with Pfizer/BioNTech’s BNT162b2 or Moderna/NIAID’s mRNA-1273 biologics as of June 11.³

The Hill recently reported that the CDC was “investigating 226 cases of myocarditis and pericarditis among young, vaccinated men.”⁷

Other Cases of Myocarditis in Teens After Vaccination

On June 11, a 19-year-old Northwestern University student, Simone Scott, died from myocarditis-induced heart failure in Chicago, Illinois six weeks after getting the second dose of the mRNA-1273 biologic. Other recent cases of myocarditis in teens following vaccination include that of a 15-year-old boy from Beaverton, Oregon and an 18-year-old boy from Kenmore, Washington—both of whom had received the second dose of the BNT162b2 biologic. In both of those cases, the boys survived.^{8 9 10}

Last month, the American Academy of Pediatrics (AAP) published a case report about seven healthy teen boys between 14 to 19 years of age who developed myocarditis or pericarditis (inflammation of the membrane surrounding the heart) within four days after the getting the second dose of the BNT162b2 biologic. They boys were hospitalized for two to six days.

Clynick’s death was reported to the Saginaw County medical examiner and the MDHHS, and the case was subsequently registered with Vaccine Adverse Event Reporting System (VAERS). “This case is currently under investigation and until the investigation is complete, it is premature to assign a specific cause of death,” the CDC said in a statement.^{1 2}

---

If you would like to receive an e-mail notice of the most recent articles published in The Vaccine Reaction each week, click here.

Click here to view References:

  AAP, American Academy of Pediatrics, BioNTech, BNT162b2, CDC, Centers for Disease Control and Prevention, COVID-19, Jacob Clynick, Marco Cáceres, MDHHS, Michigan, Michigan Department of Health and Human Service, Moderna, mRNA-1273, myocarditis, National Vaccine Information Center, NIAID, Northwestern University, NVIC, Pfizer, Saginaw, Saginaw County Health Department, Simone Scott, Tami Burages, The Hill, The Vaccine Reaction, Vaccine Adverse Event Reporting System, VAERS